Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9872413rdf:typepubmed:Citationlld:pubmed
pubmed-article:9872413lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C0064830lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C0079091lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C0079717lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C1517880lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:9872413lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:9872413pubmed:issue3lld:pubmed
pubmed-article:9872413pubmed:dateCreated1999-1-25lld:pubmed
pubmed-article:9872413pubmed:abstractTextThe cysteine-rich region (CRR) of the beta2 integrin subunit was replaced by that of beta1 to give the chimera beta2NV1. Beta2NV1 can combine with alphaL to form a variant leukocyte-function-associated antigen (LFA)-1 on COS cell surface, suggesting that the specificity of the beta2 interaction with alphaL does not lie in the CRR. Unlike those expressing wild-type LFA-1, COS cells expressing alphaL beta2NV1 are constitutively active in intercellular adhesion molecule (ICAM)-1 adhesion. These results suggest that activation of LFA-1 involves the release of an intramolecular constraint, which is maintained, in part, by the authentic beta2 CRR.lld:pubmed
pubmed-article:9872413pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:languageenglld:pubmed
pubmed-article:9872413pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:citationSubsetIMlld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9872413pubmed:statusMEDLINElld:pubmed
pubmed-article:9872413pubmed:monthDeclld:pubmed
pubmed-article:9872413pubmed:issn0014-5793lld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:ShawJ MJMlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:KayR MRMlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:HylandR HRHlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:SimmonsD LDLlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:DouglassW AWAlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:BuckleyC DCDlld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:Al-ShamkhaniA...lld:pubmed
pubmed-article:9872413pubmed:authorpubmed-author:ScarthS LSLlld:pubmed
pubmed-article:9872413pubmed:issnTypePrintlld:pubmed
pubmed-article:9872413pubmed:day4lld:pubmed
pubmed-article:9872413pubmed:volume440lld:pubmed
pubmed-article:9872413pubmed:ownerNLMlld:pubmed
pubmed-article:9872413pubmed:authorsCompleteYlld:pubmed
pubmed-article:9872413pubmed:pagination414-8lld:pubmed
pubmed-article:9872413pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:meshHeadingpubmed-meshheading:9872413-...lld:pubmed
pubmed-article:9872413pubmed:year1998lld:pubmed
pubmed-article:9872413pubmed:articleTitleThe role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding.lld:pubmed
pubmed-article:9872413pubmed:affiliationDepartment of Biochemistry, University of Oxford, UK.lld:pubmed
pubmed-article:9872413pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9872413pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9872413lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9872413lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9872413lld:pubmed